7 Ways to Reduce Inflammation Study Challenges
4 Jun 2014The following whitepaper offers seven approaches recommended by Covance to reduce common inflammation clinical study challenges. These proactive approaches are based on our experience carrying out clinical trials in this area, as well as an acknowledgement that the re-applicability of therapies to different Immune-Mediated Inflammatory Disorders (IMIDs) also enables operational improvements to the conduct of IMID clinical trials.
Links
Tags
Clinical TrialsClinical Trials, an essential part of drug discovery process, assess the safety and effectiveness of a new medication or device in the pharmaceutical industry. Clinical Trials are a phased process (Phase 0, Phase I, Phase II, Phase III and Phase IV) which begins after initial preclinical testing.RegulatoryPharmaceutical regulations impact on all areas of drug development, manufacture and control and supply. Services are provided from the early stages of drug development and clinical trials through to dossier submission, approval and marketing. Regulatory also includes submission of analytical studies from the pharmaceutical product and safety. Inflammatory Diseases
